Research at the Lady Davis Institute

Potential exists for mobile apps to play a greater role in mental health care, such as the app that helps to assess the causes of stress in a patient’s day-to-day activities.

A renewed five-year mandate has been granted to a national consortium on prescription drug safety that is headquartered in the Lady Davis Institute at the JGH.

If you think you’re sick, based on something you’ve read online, Dr. Reem el Sherif has a word to share with you: cyberchondria.

The rate of C. difficile infection among hospitalized patients drops dramatically when all patients are tested for the bacteria before being admitted to hospital, says a clinical study headed by a JGH physician and researcher.

A key to understanding the formation of the most aggressive type of brain tumour in adults has been revealed at the JGH.

It’s a scientific conundrum: Twice as many girls as boys develop anxiety and depressive disorders by the time they reach early adolescence.

Youths at risk were the focus of discussions among healthcare professionals in the mental health field at the JGH Department of Psychiatry’s 11th annual Research Day in April.

Researchers in the field of Alzheimer’s disease gathered at the JGH in May to share ideas and insights at the annual Science Day of the Consortium for the Early Identification of Alzheimer’s Disease – Quebec.

Nearly half of the heavy smokers who were admitted to hospital after a heart attack had successfully quit smoking six months after being given the drug varenicline.

People who suffer from chronic dry eye disease have new hope for relief, with the development of a promising treatment.